Masini T, Kanchar A, Mirzayev F, Viney K, et al. Wider access to quality-assured rifapentine-based regimens is needed to accelerate tuberculosis prevention and care globally. Eur Respir J 2022 Jul 1. pii: 13993003.01227-2022.
PMID: 35777762